HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, has announced its upcoming second quarter 2024 results conference call. The call is scheduled for Wednesday, August 14, 2024, at 4:30 p.m. Eastern time. CEO Branislav Vajdic, President Robert Eno, and Senior Director & Corporate Controller Ravi Malhotra will host the call, which will include discussions on Q2 results, regulatory updates, ongoing initiatives, and anticipated 2024 milestones.
A press release detailing the results will be issued before the call. Investors can access the call via phone or webcast, with a presentation available during the webcast and on the company's investor relations website. A replay of the call will be available until November 14, 2024.
HeartBeam, Inc. (NASDAQ: BEAT), un'azienda di tecnologia medica focalizzata sulla trasformazione della cura cardiaca, ha annunciato la sua prossima chiamata di conferenza sui risultati del secondo trimestre 2024. La chiamata è programmata per mercoledì 14 agosto 2024, alle 16:30 ora orientale. Il CEO Branislav Vajdic, il Presidente Robert Eno e il Direttore Senior & Controller Aziendale Ravi Malhotra saranno i relatori della chiamata, che includerà discussioni sui risultati del secondo trimestre, aggiornamenti normativi, iniziative in corso e traguardi previsti per il 2024.
Un comunicato stampa contenente i dettagli sui risultati sarà emesso prima della chiamata. Gli investitori potranno accedere alla chiamata tramite telefono o webcast, con una presentazione disponibile durante il webcast e sul sito web delle relazioni con gli investitori dell'azienda. Una registrazione della chiamata sarà disponibile fino al 14 novembre 2024.
HeartBeam, Inc. (NASDAQ: BEAT), una empresa de tecnología médica centrada en transformar el cuidado cardíaco, ha anunciado su próxima conferencia de resultados del segundo trimestre de 2024. La llamada está programada para miércoles 14 de agosto de 2024, a las 4:30 p.m. hora del este. El CEO Branislav Vajdic, el Presidente Robert Eno y el Director Senior y Controlador Corporativo Ravi Malhotra serán los anfitriones de la llamada, que incluirá discusiones sobre los resultados del segundo trimestre, actualizaciones regulatorias, iniciativas en curso y hitos anticipados para 2024.
Se emitirá un comunicado de prensa detallando los resultados antes de la llamada. Los inversores podrán acceder a la llamada a través de teléfono o webcast, con una presentación disponible durante el webcast y en el sitio web de relaciones con los inversores de la empresa. Una grabación de la llamada estará disponible hasta el 14 de noviembre de 2024.
HeartBeam, Inc. (NASDAQ: BEAT), 심장 치료의 혁신을 목표로 하는 의료 기술 회사가 2024년 2분기 실적 컨퍼런스 콜을 발표했습니다. 이 콜은 2024년 8월 14일 수요일, 동부 표준시 오후 4:30에 예정되어 있습니다. CEO Branislav Vajdic, 사장 Robert Eno, 그리고 선임 이사 및 기업 회계 담당 Ravi Malhotra가 콜을 주최하며, 2분기 실적, 규제 업데이트, 진행 중인 이니셔티브, 2024년 예상 이정표에 대해 논의할 예정입니다.
실적에 대한 세부 내용이 담긴 보도 자료가 콜 전에 발표될 계획입니다. 투자자들은 전화 또는 웹캐스트를 통해 콜에 접속할 수 있으며, 웹캐스트 중 프레젠테이션도 제공되고 회사 투자자 관계 웹사이트에서도 확인할 수 있습니다. 콜의 녹화본은 2024년 11월 14일까지 이용 가능합니다.
HeartBeam, Inc. (NASDAQ: BEAT), une entreprise de technologie médicale axée sur la transformation des soins cardiaques, a annoncé sa prochaine conférence téléphonique sur les résultats du deuxième trimestre 2024. L'appel est prévu pour mercredi 14 août 2024, à 16 h 30, heure de l'Est. Le PDG Branislav Vajdic, le Président Robert Eno et le Directeur senior et Contrôleur d'entreprise Ravi Malhotra seront les hôtes de l'appel, qui comprendra des discussions sur les résultats du T2, les mises à jour réglementaires, les initiatives en cours et les jalons prévus pour 2024.
Un communiqué de presse détaillant les résultats sera publié avant l'appel. Les investisseurs pourront accéder à l'appel par téléphone ou par webinaire, avec une présentation disponible pendant le webinaire et sur le site web des relations investisseurs de l'entreprise. Un enregistrement de l'appel sera disponible jusqu'au 14 novembre 2024.
HeartBeam, Inc. (NASDAQ: BEAT), ein Medizintechnikunternehmen, das sich auf die Transformation der kardiologischen Versorgung konzentriert, hat seine bevorstehende Konferenzschaltung zu den Ergebnissen des zweiten Quartals 2024 angekündigt. Die Verbindung ist für Mittwoch, den 14. August 2024, um 16:30 Uhr Eastern Time angesetzt. CEO Branislav Vajdic, Präsident Robert Eno und Senior Director & Corporate Controller Ravi Malhotra werden die Schaltung leiten, die Diskussionen über die Ergebnisse des zweiten Quartals, regulatorische Updates, laufende Initiativen und erwartete Meilensteine für 2024 umfassen wird.
Vor der Schaltung wird eine Pressemitteilung mit den Ergebnissen veröffentlicht. Investoren können über Telefon oder Webcast auf die Schaltung zugreifen, wobei während des Webcasts und auf der Investor-Relations-Website des Unternehmens eine Präsentation verfügbar ist. Eine Aufzeichnung der Schaltung wird bis zum 14. November 2024 verfügbar sein.
- None.
- None.
HeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno, and Senior Director & Corporate Controller Ravi Malhotra will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.
To access the call, please use the following information:
Date: |
Wednesday, August 14, 2024 |
Time: |
4:30 p.m. Eastern time (1:30 p.m. Pacific time) |
Dial-in: |
1-844-826-3035 |
International Dial-in: |
1-412-317-5195 |
Conference Code: |
10191273 |
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1681274&tp_key=132aeeb1d7 |
A telephone replay will be available approximately three hours after the call and will run through November 14, 2024, by dialing 1-844-512-2921 from the
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company that is dedicated to transforming cardiac care through the power of personalized insights. The company’s proprietary vectorelectrocardiography (VECG) technology collects 3D signals of the heart’s electrical activity and converts them into a 12-lead ECG. This platform technology is designed to be used on portable, patient-friendly devices such as a credit-card sized monitor, watch or patch. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining how cardiac health is managed in the future. For additional information, visit HeartBeam.com.
Forward-Looking Statements
All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240801513575/en/
Investor Relations Contact:
Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
BEAT@mzgroup.us
www.mzgroup.us
Media Contact:
media@heartbeam.com
Source: HeartBeam, Inc.
FAQ
When is HeartBeam's Q2 2024 earnings call scheduled?
What will be discussed in HeartBeam's Q2 2024 earnings call?
How can investors access HeartBeam's Q2 2024 earnings call?
Will there be a replay available for HeartBeam's Q2 2024 earnings call?
